Enzyme-sensitive nanomaterials for efficient capture of cancer cells and preparation methods and applications thereof
By designing a three-layer enzyme-sensitive nanomaterial, the problem of capturing and releasing circulating tumor cells in vivo using magnetic nanoparticles has been solved, achieving efficient capture and non-destructive release, and is suitable for in vitro blood sample detection.
Patent Information
- Application Number
- CN202111120391.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-09-24
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2041-09-24
AI Technical Summary
In existing technologies, the surface modification possibilities for magnetic nanoparticles in vivo are limited, making it difficult to efficiently capture circulating tumor cells and achieve non-destructive release for subsequent research.
A three-layer enzyme-sensitive nanomaterial was designed, comprising a magnetic core of iron oxide, an enzyme-sensitive polymer intermediate layer, and an outermost layer that recognizes cancer cells. Positively charged nanoparticles were prepared by adsorption of positive and negative charges for efficient capture and non-destructive release via amylase hydrolysis.
It achieves efficient capture of circulating tumor cells and releases them non-destructively through enzymatic hydrolysis, making it suitable for in vitro blood sample detection. This avoids in vivo biosafety and size limitations, and the released cells can be directly used for subsequent research.
Smart Images

Figure CN113866073B_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of nanomaterials, and relates to a surface-modified nanomaterial, in particular to an enzyme-sensitive nanomaterial for efficiently capturing cancer cells, and a preparation method and application thereof. Background Art
[0002] Circulating tumor cells have very high potential research value in cancer treatment due to their non-invasive detection method, convenient and timely sampling, and homology with the primary lesion site. After being surface-modified with antibodies or charged polymer materials, magnetic nanoparticles can tightly bind to cancer cells in the blood through antigen-antibody reactions or the attraction of opposite charges. Researchers hope to be able to release captured circulating tumor cells so that in-depth follow-up research on circulating tumor cells from patients can be carried out. Therefore, it is of great significance to invent an enzyme-sensitive nanomaterial that can efficiently capture cancer cells.
[0003] There are many kinds of nanomaterials for biomedicine in the prior art, and most of them are used in vivo for tumor cell detection. For example, Chinese patent application CN1822254A discloses a method for preparing magnetic nanoparticles wrapped by hydrophilic organic polymers, which are used in biomedical fields such as cell separation, tumor hyperthermia, magnetic resonance imaging and targeted drug delivery. It includes the preparation of magnetic fluid and surface aldehyde modification, which is achieved by adding iron salt solution to starch solution and stirring under nitrogen protection, adjusting the pH of the solution to 10-11 and stirring at 60-80°C for 1-2 hours, removing impurities to obtain magnetic starch composite nanoparticles rich in hydroxyl groups on the surface, and uniformly dispersing them in the aqueous phase to obtain the magnetic fluid; then adding sodium periodate to the magnetic fluid sample, and performing oxidation reaction under nitrogen protection in the dark to obtain magnetic starch composite nanoparticles rich in aldehyde groups on the surface. Chinese patent application CN1993469A discloses a nanoparticle composed of a magnetic iron oxide core and a natural polymer shell, which comprises dissolving the polymer in an acidic solution, adding γ-Fe2O3 particles as an aqueous phase, paraffin, a surfactant, and a co-surfactant as an oil phase, and mixing the two to obtain an oil-in-water type reverse microemulsion, and then adding a cross-linking agent, stirring, washing, and removing impurities to obtain the product. The above two prior arts are all considered for in vivo application, which greatly limits the possibility of surface modification of magnetic nanoparticles. For example, if a positively charged polymer is to be modified on the surface, it is difficult to be applied in vivo. Summary of the invention
[0004] Technical problem to be solved: In order to overcome the deficiencies of the prior art, obtain magnetic nanoparticles for capturing circulating tumor cells, and specifically for in vitro blood sample detection, the present invention provides enzyme-sensitive nanomaterials for efficiently capturing cancer cells, as well as preparation methods and applications.
[0005] Technical solution: Enzyme-sensitive nanomaterials for efficiently capturing cancer cells. The nanomaterials are positively charged magnetic nanoparticles with a three-layer structure. The three-layer structure is as follows: the outermost layer is an effector polymer layer for identifying and capturing cancer cells, the middle layer is an enzyme-sensitive polymer layer, and the inner core is ferroferric oxide.
[0006] Preferably, the outermost layer is an antibody or a positively charged polymer, and the middle layer is amylose.
[0007] Preferably, the positively charged polymer is polyethyleneimine, chitosan or aminopolyethylene glycol.
[0008] The method for preparing any of the above enzyme-sensitive nanomaterials for efficiently capturing cancer cells comprises first wrapping amylose on the surface of ferroferric oxide magnetic particles to make them negatively charged, and then modifying the surface of the amylose layer with antibodies or positively charged polymers based on the principle of positive and negative charge adsorption, thereby preparing an enzyme-sensitive nanomaterial with a positively charged surface.
[0009] Preferably, the method specifically comprises the following steps:
[0010] S1: add dimethyl sulfoxide (DMSO) to deionized water, the volume ratio of dimethyl sulfoxide (DMSO) to deionized water is 9:1;
[0011] S2: dissolving amylose in the solution prepared in S1, with the volume ratio of amylose mass to solution being 1-5:1, in a 90°C water bath until the starch is fully gelatinized, and then cooling to room temperature;
[0012] S3: adding ferroferric oxide nanoparticles to the gelatinized starch in S2 and uniformly dispersing them by ultrasonic, adding anhydrous ethanol dropwise, continuing to uniformly disperse them by ultrasonic, and then performing magnetic separation and washing to obtain starch-coated magnetic nanoparticles, wherein the mass ratio of ferroferric oxide nanoparticles to amylose is 1:25, and the volume ratio of anhydrous ethanol to gelatinized starch is 1-2.5:1;
[0013] S4: Disperse the starch-coated magnetic nanoparticles in anhydrous methanol, and add 0.8-1 mg / mL of PEI methanol solution; or add 0.5-1 mg / mL of chitosan acetic acid solution, wherein the acetic acid concentration is 1%; or add 0.5-1 mg / mL of PEG-NH2 aqueous solution, stir evenly by ultrasonication, and then separate to obtain enzyme-sensitive nanomaterials.
[0014] Preferably, the mass ratio of PEI to magnetic nanoparticles in S4 is 1:1-1.5.
[0015] Use of any of the above enzyme-sensitive nanomaterials for efficiently capturing cancer cells in the preparation of a kit for capturing cancer cells in an ex vivo blood sample.
[0016] The principle of the enzyme-sensitive nanomaterial of the present invention for efficiently capturing cancer cells is that the enzyme-sensitive nanomaterial of the present invention has a three-layer structure, specifically a magnetic inner core of ferroferric oxide, an enzyme-sensitive polymer middle layer, and an outermost layer for identifying and capturing cancer cells. The nanomaterial of the present invention with a three-layer core-shell structure can quickly and efficiently identify and capture circulating tumor cells in ex vivo blood through the outermost layer, and then achieve lossless and low-loss release of cancer cells through amylase hydrolysis, thereby using the circulating tumor cells for subsequent research.
[0017] Beneficial effects: (1) The enzyme-sensitive nanomaterials of the present invention can efficiently capture circulating tumor cells in ex vivo blood samples and achieve lossless and low-loss release without considering their in vivo biosafety and the limitations of nanomaterial size; (2) Tumor cells can be released only by amylase hydrolysis, so the released circulating tumor cells can be directly used for subsequent research. BRIEF DESCRIPTION OF THE DRAWINGS
[0018] Figure 1 It is a simulated diagram of the three-layer structure of the enzyme-sensitive nanomaterial of the present invention;
[0019] Figure 2 is a simulation diagram of the enzyme-sensitive nanomaterial capturing circulating tumor cells and releasing them by enzymatic degradation;
[0020] Figure 3 This is a transmission electron microscopy image of magnetic nanoparticles modified with starch;
[0021] Figure 4 It is the potential diagram of the nanomaterial after being modified with a positively charged polymer layer;
[0022] Figure 5 is a capture rate versus release rate graph. DETAILED DESCRIPTION
[0023] The following examples further illustrate the content of the present invention, but should not be construed as limiting the present invention. Without departing from the spirit and essence of the present invention, modifications and substitutions made to the method, steps or conditions of the present invention all belong to the scope of the present invention. Unless otherwise specified, the technical means used in the examples are conventional means well known to those skilled in the art.
[0024] Example 1
[0025] The enzyme-sensitive nanomaterial described in this example is prepared by the following method:
[0026] (1) Take 45 mL of DMSO and add 5 mL of deionized water to make the DMSO:water (volume ratio) = 9:1;
[0027] (2) Weigh 100 mg of amylose and dissolve it in the above solution, with the ratio of amylose mass to solution volume being 5:1 to 1:1, and place in a water bath at 90° C. to fully gelatinize the starch;
[0028] (3) After cooling to room temperature, 4 mg of ferrosoferric oxide nanoparticles were added and dispersed evenly by ultrasonication;
[0029] (4) Add anhydrous ethanol dropwise and continue sonication. The volume of anhydrous ethanol is 50-125 mL.
[0030] (5) magnetic separation and washing to obtain starch-coated magnetic nanoparticles;
[0031] (6) The above product was dissolved in 25 mL of anhydrous methanol and ultrasonically stirred for 15 minutes to uniformly disperse the nanoparticles;
[0032] (7) Weigh 3-5 mg of PEI (Mw = 10000) and dissolve it in 5 ml of anhydrous methanol. Add it dropwise to the solution. Stir under ultrasonication for 2 hours.
[0033] (8) Magnetic separation and washing can obtain three-layered nanoparticles with positive magnetic properties.
[0034] Result analysis: Figure 3 After starch modification, it can be seen that the nanoparticles modified by starch show film-like adhesion. And further modification of PEI changes the charge from negative to positive.
[0035] Example 2
[0036] The difference from Example 1 is that in step (7), 2.5-5 mg of chitosan is weighed and dissolved in 5 ml of 1% acetic acid, added dropwise to the solution, and ultrasonically stirred for 2 hours; thereby preparing three-layer positively charged electromagnetic nanoparticles with chitosan as the positively charged polymer.
[0037] Result analysis: Figure 4 As shown, after modification of chitosan, the surface charge changed from negative to positive.
[0038] Example 3
[0039] The difference from Example 1 is that in step (7), 2.5-5 mg of PEG-NH2 is weighed and dissolved in 5 ml of deionized water, added dropwise to the solution, and ultrasonically stirred for 2 hours; thereby preparing positively charged electromagnetic nanoparticles with a three-layer structure in which the positively charged polymer is amino polyethylene glycol.
[0040] Result analysis: Figure 4 As shown, after modification with PEG-HN2, the surface charge changed from negative to positive.
[0041] Example 4
[0042] Cancer cell capture was performed using the enzyme-sensitive nanomaterial prepared in Example 1:
[0043] (1) Add a known amount of cancer cells to a quantitative PBS to obtain the initial cancer cell concentration;
[0044] (2) The enzyme-sensitive nanomaterial of the present invention was added to (1) at a concentration of 40 μg / mL and incubated at 4°C for 10 minutes.
[0045] (3) performing magnetic separation on (2) using a magnet or a magnetic stand, taking the supernatant and counting it for calculating the off-target rate;
[0046] (4) Take the precipitate and add 4 mg / mL low-temperature α-amylase, adjust the pH to 6, and incubate at 37°C for 10-30 minutes
[0047] (5) Use a magnet or a magnetic rack to perform magnetic separation on (4), and take the supernatant and count it for calculating the release rate.
[0048] Result analysis: Figure 5 As shown, after calculation of the off-target rate, the capture rate can reach more than 90%; the release rate can reach 80%.
Claims
1. A method for preparing an enzyme-sensitive nanomaterial for efficiently capturing cancer cells, characterized in that: The method firstly wraps amylose on the surface of ferroferric oxide magnetic particles to make them negatively charged, and then performs surface modification of positively charged polymers outside the amylose layer based on the principle of positive and negative charge adsorption, thereby preparing an enzyme-sensitive nanomaterial with a positively charged surface; the method specifically comprises the following steps: S1: Measure DMSO and add it into deionized water, the volume ratio of DMSO to deionized water is 9:1; S2: dissolving amylose in the solution prepared in S1, with the volume ratio of amylose mass to solution being 1-5:1, in a 90°C water bath until the starch is fully gelatinized, and then cooling to room temperature; S3: adding ferroferric oxide nanoparticles to the gelatinized starch in S2 and uniformly dispersing them by ultrasonic, adding anhydrous ethanol dropwise, continuing to uniformly disperse them by ultrasonic, and then performing magnetic separation and washing to obtain starch-coated magnetic nanoparticles, wherein the mass ratio of ferroferric oxide nanoparticles to amylose is 1:25, and the volume ratio of anhydrous ethanol to gelatinized starch is 1-2.5:1; S4: Disperse the starch-coated magnetic nanoparticles in anhydrous methanol, and add 0.8-1 mg / mL of PEI methanol solution; or add 0.5-1 mg / mL of chitosan acetic acid solution, wherein the acetic acid concentration is 1%; or add 0.5-1 mg / mL of PEG-NH2 aqueous solution, stir evenly with ultrasound, and then separate to obtain enzyme-sensitive nanomaterials.
2. The method for preparing an enzyme-sensitive nanomaterial for efficiently capturing cancer cells according to claim 1, characterized in that: The mass ratio of PEI to magnetic nanoparticles in S4 is 1:1-1.
5.
3. An enzyme-sensitive nanomaterial for efficiently capturing cancer cells prepared according to the method of claim 1 or 2.
4. Use of the enzyme-sensitive nanomaterial for efficiently capturing cancer cells as claimed in claim 3 in preparing a kit for capturing cancer cells in an ex vivo blood sample.
